Gruenenthal Looks Beyond Pain For Transformative Deals

Gabriel Baertschi, Gruenenthal’s recently appointed CEO, explains to Mike Ward, global director of content for Informa’s Pharma Intelligence Insights portfolio, how he intends to grow revenues, replenish the pipeline, expand the global footprint and transform the culture of the company.